Shows
NEJM InterviewsNEJM Interview: Rohan Khazanchi on the gradual but incomplete shift to race-free equations for interpreting pulmonary function tests.Watch the NEJM In Studio video of this interview at NEJM.org. Rohan Khazanchi is a research affiliate at the FXB Center for Health and Human Rights at Harvard University and a resident in the Harvard Medicine-Pediatrics Residency Program. Harleen Marwah, the interviewer, is a recent Editorial Fellow at the Journal. R. Khazanchi and Others. Reform and Remedy for Imprecision and Inequity — Ending the Race-Based Evaluation of Occupational Pulmonary Impairment. N Engl J Med 2025;393:508-514.
2025-07-3030 min
NEJM InterviewsNEJM Interview: David Jones on the disparate historical approaches to anemia diagnosis and their lessons for physicians.Watch the NEJM In Studio video of this interview at NEJM.org. David Jones is the Ackerman Professor of the Culture of Medicine at Harvard University. Harleen Marwah, the interviewer, is an Editorial Fellow at the Journal. W. Xue and D.S. Jones. Debating Race and the Diagnosis of Anemia — How Medicine Moved Away from Race-Based Standards. N Engl J Med 2025;392:2168-2173.
2025-06-0440 min
NEJM InterviewsNEJM Outbreaks Updates — H5N1 in IndianaIn this NEJM Outbreaks Update, Editor-in-Chief Eric Rubin and Deputy Editor Lindsey Baden are joined by Indiana Commissioner of Public Health Lindsay Weaver to discuss the current state of avian influenza in Indiana. Eric Rubin is the Editor-in-Chief of the Journal. Lindsey Baden is a Deputy Editor of the Journal. Lindsay Weaver is the Indiana Commissioner of Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E.J. Rubin and Others. NEJM Outbreaks Updates — H5N1 in Indiana. N Engl J Med. DOI: 10.1056/NEJMe2503583.
2025-04-2220 min
NEJM InterviewsNEJM Outbreaks Update — H5N1: A View from the StatesIn this audio interview, Editor-in-Chief Eric Rubin and Deputy Editor Lindsey Baden are joined by state public health leaders Robbie Goldstein and Jennifer Shuford to discuss action against H5N1 in Massachusetts and Texas and across the nation. Eric Rubin is the Editor-in-Chief of the Journal. Lindsey Baden is a Deputy Editor of the Journal. Robert Goldstein is the Massachusetts Commissioner of Public Health. Jennifer Shuford is the Commissioner of the Texas Department of State Health Services. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E.J. Rubin and Others. NEJM Outbreaks Update — H5N1: A Vi...
2025-03-1134 min
NEJM InterviewsNEJM Outbreaks Update — H5N1In this NEJM Outbreaks Update, Editor-in-Chief Eric Rubin and Deputy Editor Lindsey Baden are joined by veterinarian and virologist Yoshihiro Kawaoka to discuss avian influenza and its current impact on chickens, cows, cats, and humans. Eric Rubin is the Editor-in-Chief of the Journal. Lindsey Baden is a Deputy Editor of the Journal. Yoshihiro Kawaoka is a veterinarian and virologist and a professor at the University of Wisconsin-Madison and the University of Tokyo. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E.J. Rubin and Others. NEJM Outbreaks Update — H5N1. N Engl J Med. DOI: 10.1056/NEJMe2502267.
2025-03-0419 min
NEJM AI Grand RoundsHealth Care at the Breaking Point: Dr. Zak Kohane Returns to NEJM AI Grand RoundsIn this return appearance on NEJM AI Grand Rounds, Dr. Zak Kohane joins hosts Raj Manrai and Andy Beam to discuss the evolving landscape of AI in medicine. As the first repeat guest on the show, Dr. Kohane shares insights on health care system challenges, the Human Values Project, and his perspectives on the most significant AI developments of 2024. The conversation explores everything from the practical applications of AI in health care to philosophical discussions about machine psychology and the future of doctor-patient relationships.
Transcript.
2025-01-151h 08
NEJM InterviewsNEJM at AHA — Phase 1 Study of AAV9.LAMP2B Gene Therapy in Danon DiseaseEric Rubin is the Editor-in-Chief of the Journal. Jane Leopold is a Deputy Editor of the Journal. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E.J. Rubin, J. Leopold, and S. Morrissey. NEJM at AHA — Phase 1 Study of AAV9.LAMP2B Gene Therapy in Danon Disease. N Engl J Med. DOI: 10.1056/NEJMe2414477.
2024-11-1704 minNEJM InterviewsNEJM at AHA — Routine Spironolactone in Acute Myocardial InfarctionEric Rubin is the Editor-in-Chief of the Journal. Jane Leopold is a Deputy Editor of the Journal. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E.J. Rubin, J. Leopold, and S. Morrissey. NEJM at AHA — Routine Spironolactone in Acute Myocardial Infarction. N Engl J Med. DOI: 10.1056/NEJMe2414472.
2024-11-1603 minNEJM InterviewsNEJM at AHA — Intensive Blood-Pressure Control in Patients with Type 2 DiabetesEric Rubin is the Editor-in-Chief of the Journal. Jane Leopold is a Deputy Editor of the Journal. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E.J. Rubin, J. Leopold, and S. Morrissey. NEJM at AHA — Intensive Blood-Pressure Control in Patients with Type 2 Diabetes. N Engl J Med. DOI: 10.1056/NEJMe2414476.
2024-11-1503 minNEJM InterviewsNEJM at AHA — Tirzepatide for Heart Failure with Preserved Ejection Fraction and ObesityEric Rubin is the Editor-in-Chief of the Journal. Jane Leopold is a Deputy Editor of the Journal. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E.J. Rubin, J. Leopold, and S. Morrissey. NEJM at AHA — Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity. N Engl J Med. DOI: 10.1056/NEJMe2414470.
2024-11-1504 minNEJM InterviewsNEJM at AHA — CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR CardiomyopathyEric Rubin is the Editor-in-Chief of the Journal. Jane Leopold is a Deputy Editor of the Journal. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E.J. Rubin, J. Leopold, and S. Morrissey. NEJM at AHA — CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR Cardiomyopathy. N Engl J Med. DOI: 10.1056/NEJMe2414473.
2024-11-1503 minNEJM InterviewsNEJM at AHA — Catheter Ablation or Antiarrhythmic Drugs for Ventricular TachycardiaEric Rubin is the Editor-in-Chief of the Journal. Jane Leopold is a Deputy Editor of the Journal. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E.J. Rubin, J. Leopold, and S. Morrissey. NEJM at AHA — Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia. N Engl J Med. DOI: 10.1056/NEJMe2414471.
2024-11-1502 minNEJM InterviewsNEJM at AHA — Left Atrial Appendage Closure after Ablation for Atrial FibrillationEric Rubin is the Editor-in-Chief of the Journal. Jane Leopold is a Deputy Editor of the Journal. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E.J. Rubin, J. Leopold, and S. Morrissey. NEJM at AHA — Left Atrial Appendage Closure after Ablation for Atrial Fibrillation. N Engl J Med. DOI: 10.1056/NEJMe2414475.
2024-11-1504 min
NEJM InterviewsNEJM at ESMO — Zolbetuximab in Gastric or Gastroesophageal Junction AdenocarcinomaDid you miss the ESMO Congress 2024? Listen here: NEJM Editor-in-Chief Eric Rubin and NEJM Evidence Associate Editor Oladapo Yeku discuss research that was presented at the 2024 European Society of Medical Oncology annual meeting. Visit NEJM.org to read the latest research.
2024-09-1502 minNEJM InterviewsNEJM at ESMO — Phase 3 Trial of Cabozantinib in Advanced Neuroendocrine TumorsDid you miss the ESMO Congress 2024? Listen here: NEJM Editor-in-Chief Eric Rubin and NEJM Evidence Associate Editor Oladapo Yeku discuss research that was presented at the 2024 European Society of Medical Oncology annual meeting. Visit NEJM.org to read the latest research.
2024-09-1502 minNEJM InterviewsNEJM at ESMO — Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial CarcinomaDid you miss the ESMO Congress 2024? Listen here: NEJM Editor-in-Chief Eric Rubin and NEJM Evidence Associate Editor Oladapo Yeku discuss research that was presented at the 2024 European Society of Medical Oncology annual meeting. Visit NEJM.org to read the latest research.
2024-09-1403 minNEJM InterviewsNEJM at ESMO — Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced MelanomaDid you miss the ESMO Congress 2024? Listen here: NEJM Editor-in-Chief Eric Rubin and NEJM Evidence Associate Editor Oladapo Yeku discuss research that was presented at the 2024 European Society of Medical Oncology annual meeting. Visit NEJM.org to read the latest research.
2024-09-1403 minNEJM InterviewsNEJM at ESMO — Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder CancerDid you miss the ESMO Congress 2024? Listen here: NEJM Editor-in-Chief Eric Rubin and NEJM Evidence Associate Editor Oladapo Yeku discuss research that was presented at the 2024 European Society of Medical Oncology annual meeting. Visit NEJM.org to read the latest research.
2024-09-1403 minNEJM InterviewsNEJM at ESMO — Overall Survival with Pembrolizumab in Early-Stage Triple- Negative Breast CancerDid you miss the ESMO Congress 2024? Listen here: NEJM Editor-in-Chief Eric Rubin and NEJM Evidence Associate Editor Oladapo Yeku discuss research that was presented at the 2024 European Society of Medical Oncology annual meeting. Visit NEJM.org to read the latest research.
2024-09-1403 minNEJM InterviewsNEJM at ESMO — Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast CancerDid you miss the ESMO Congress 2024? Listen here: NEJM Editor-in-Chief Eric Rubin and NEJM Evidence Associate Editor Oladapo Yeku discuss research that was presented at the 2024 European Society of Medical Oncology annual meeting. Visit NEJM.org to read the latest research.
2024-09-1403 minNEJM InterviewsNEJM at ESMO — Pembrolizumab in HER2+ Gastric CancerDid you miss the ESMO Congress 2024? Listen here: NEJM Editor-in-Chief Eric Rubin and NEJM Evidence Associate Editor Oladapo Yeku discuss research that was presented at the 2024 European Society of Medical Oncology annual meeting. Visit NEJM.org to read the latest research.
2024-09-1302 minNEJM InterviewsNEJM at ESMO — Ponsegromab in Cancer CachexiaDid you miss the ESMO Congress 2024? Listen here: NEJM Editor-in-Chief Eric Rubin and NEJM Evidence Associate Editor Oladapo Yeku discuss research that was presented at the 2024 European Society of Medical Oncology annual meeting. Visit NEJM.org to read the latest research.
2024-09-1302 minNEJM InterviewsNEJM at ESMO — Preoperative Chemoradiotherapy for Resectable Gastric CancerDid you miss the ESMO Congress 2024? Listen here: NEJM Editor-in-Chief Eric Rubin and NEJM Evidence Associate Editor Oladapo Yeku discuss research that was presented at the 2024 European Society of Medical Oncology annual meeting. Visit NEJM.org to read the latest research.
2024-09-1302 minNEJM InterviewsNEJM at ESC — Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis RiskDid you miss the ESC Congress 2024? In a series of audio interviews (featured below), Editor-in-Chief Eric Rubin and Deputy Editor Jane Leopold discuss research that was presented at the 2024 European Society of Cardiology annual meeting. Visit NEJM.org to read the latest research.
2024-09-0102 minNEJM InterviewsNEJM at ESC — Asundexian versus Apixaban in Patients with Atrial FibrillationDid you miss the ESC Congress 2024? In this podcast, Editor-in-Chief Eric Rubin and Deputy Editor Jane Leopold discuss research that was presented at the 2024 European Society of Cardiology annual meeting. Visit NEJM.org to read the latest research.
2024-08-3103 minNEJM InterviewsNEJM at ESC — Edoxaban Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Artery DiseaseDid you miss the ESC Congress 2024? In this podcast, Editor-in-Chief Eric Rubin and Deputy Editor Jane Leopold discuss research that was presented at the 2024 European Society of Cardiology annual meeting. Visit NEJM.org to read the latest research.
2024-08-3104 minNEJM InterviewsNEJM at ESC — Invasive versus Conservative Strategy for Older Patients with Myocardial InfarctionDid you miss the ESC Congress 2024? In this podcast, Editor-in-Chief Eric Rubin and Deputy Editor Jane Leopold discuss research that was presented at the 2024 European Society of Cardiology annual meeting. Visit NEJM.org to read the latest research.
2024-08-3103 minNEJM InterviewsNEJM at ESC — Finerenone in Heart Failure for Mildly Reduced or Preserved Ejection FractionDid you miss the ESC Congress 2024? In this podcast, Editor-in-Chief Eric Rubin and Deputy Editor Jane Leopold discuss research that was presented at the 2024 European Society of Cardiology annual meeting. Have a listen! Visit NEJM.org to read the latest research.
2024-08-3103 minNEJM InterviewsNEJM at ESC — Inflammation, Cholesterol, Lipoprotein(a) and 30-Year Cardiovascular Outcomes in WomenDid you miss the ESC Congress 2024? In this podcast, Editor-in-Chief Eric Rubin and Deputy Editor Jane Leopold discuss research that was presented at the 2024 European Society of Cardiology annual meeting. Visit NEJM.org to read the latest research.
2024-08-3003 minNEJM InterviewsNEJM at ESC — Transcatheter Valve Repair in Heart Failure with Moderate to Severe Mitral RegurgitationDid you miss the ESC Congress 2024? In this podcast, Editor-in-Chief Eric Rubin and Deputy Editor Jane Leopold discuss research that was presented at the 2024 European Society of Cardiology annual meeting. Visit NEJM.org to read the latest research.
2024-08-3003 minNEJM InterviewsNEJM at ESC — Transcatheter Repair versus Surgery for Secondary Mitral RegurgitationDid you miss the ESC Congress 2024? In this podcast, Editor-in-Chief Eric Rubin and Deputy Editor Jane Leopold discuss research that was presented at the 2024 European Society of Cardiology annual meeting. Visit NEJM.org to read the latest research.
2024-08-3003 minNEJM InterviewsNEJM at ESC — Continuation versus Interruption of Oral Anticoagulation during TAVDid you miss the ESC Congress 2024? In this podcast, Editor-in-Chief Eric Rubin and Deputy Editor Jane Leopold discuss research that was presented at the 2024 European Society of Cardiology annual meeting. Visit NEJM.org to read the latest research.
2024-08-3004 minNEJM InterviewsNEJM at ESC — PCI in Patients Undergoing Transcatheter Aortic-Valve ImplantationDid you miss the ESC Congress 2024? In this podcast, Editor-in-Chief Eric Rubin and Deputy Editor Jane Leopold discuss research that was presented at the 2024 European Society of Cardiology annual meeting. Visit NEJM.org to read the latest research.
2024-08-3004 minNEJM InterviewsNEJM at ESC — Beta Blocker Interruption or Continuation with Prior Myocardial InfarctionDid you miss the ESC Congress 2024? In this podcast, Editor-in-Chief Eric Rubin and Deputy Editor Jane Leopold discuss research that was presented at the 2024 European Society of Cardiology annual meeting. Visit NEJM.org to read the latest research.
2024-08-2903 minNEJM InterviewsNEJM at ESC — Vutrisiran in Patients with Transthyretin Amyloidosis with CardiomyopathyDid you miss the ESC Congress 2024? In this podcast, Editor-in-Chief Eric Rubin and Deputy Editor Jane Leopold discuss research that was presented at the 2024 European Society of Cardiology annual meeting. Visit NEJM.org to read the latest research.
2024-08-2903 min
Intention to TreatCovid Vaccines — Playing the Long GameIn this first episode of “Intention to Treat,” NEJM editor-in-chief Eric Rubin and his colleague at the FDA Vaccine Advisory Committee, Paul Offit, consider the achievements, limitations, and expectations of Covid vaccines.
A transcript of this episode is available at nejm.org/doi/full/10.1056/NEJMp2300222.
2023-01-2535 min
NEJM InterviewsNEJM AI Grand RoundsNEJM AI Grand Rounds, hosted by Arjun (Raj) Manrai, Ph.D. and Andrew Beam, Ph.D., features informal conversations with a variety of unique experts exploring the deep issues at the intersection of artificial intelligence, machine learning, and medicine. You’ll learn how AI will change clinical practice and healthcare, how it will impact the patient experience, and about the people who are pushing for innovation. Whether you are an AI researcher or a practicing clinician, these conversations will enlighten and surprise you as we journey through this very exciting field. Produced by NEJM Group.
2022-12-2101 minNEJM AI Grand RoundsTrailer: Introducing NEJM AI Grand Rounds Podcast
[Transcript]
How will AI change clinical practice and healthcare, and how will it impact the patient experience? Who are the people pushing for change and what are their goals? These are just a few of the topics that we hope to explore on NEJM AI Grand Rounds, a new podcast from NEJM Group. This podcast will be an informal conversation with a variety of unique experts exploring the deep issues at the intersection of artificial intelligence and medicine. Whether you are an AI researcher or a practicing clinician, we hope these conversations will enlighten and...
2022-12-0501 min
Clinical ConversationsPodcast 301: Monkeypox — what to look for, how to treatA VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE HERE.
This time, we look to New York for guidance on recognizing and treating monkeypox.
Dr. Eric Meyerowitz of Montefiore and Dr. Stephen Baum of Einstein will lead you through the monkeypox thicket in a 17-minute chat.
Included below is information for patients as well as links to some key articles of interest to clinicians.
LINKS:
For patients: Dr. Barry Zingman’s “Monkeypox — What you need to know”
For clinicians:
NEJM article on monkeypox in 16 countries
NEJM Case Records...
2022-08-1917 minClinical ConversationsPodcast 299: Lung cancer and atezolizumab — results from the IMpower010 trialA VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE HERE.
Interim results on overall survival in phase 3 of the IMpower010 trial were presented at this year’s meeting of the International Assosciation for the Study of Lung Cancer (IASLC). As part of the NEJM Group’s coverage of the conference, Christine Sadlowski interviewed the presenter, Dr. Enriqueta Felip. In a 15-minute interview, she discusses the implications for different patient groups and the past, present, and future of the IMpower trial, which tests adjuvant atezolizumab following platinum-based chemotherapy in patients with resected early-stage non–small-cell lung cancer.
INTERVI...
2022-08-1014 minClinical ConversationsPodcast 298: COPD exacerbations — 7 days of antibiotics versus 2A VIDEO RECORDING OF THIS INTERVIEW IS AVAILABLE AT THIS LINK.
In treating most exacerbations of chronic obstructive pulmonary disease (COPD) the usual regimen consists of prednisone plus 5- to 7-days of antibiotics. But what if a shorter course of antibiotic therapy would do? That would be both convenient for patients and less likely to promote antibiotic resistance.
A recent paper in Therapeutic Advances in Respiratory Disease describes just such a strategy: patients received prednisone plus either 2 or 7 days of levofloxacin. There was no substantive difference in clinical results between the groups. Summarized in NEJM...
2022-08-0214 minClinical ConversationsPodcast 295: How should clinicians manage severe (but asymptomatic) carotid artery stenosis while awaiting CREST-2’s results?CREST-2’s results are probably more than a year away. In the meantime, what to do about diagnosed severe (but asymptomatic) carotid stenosis? Recent results suggest that medical management compares favorably with the surgical approach.
In this edition, we address the question with a conversation between Dr. Allan Brett, NEJM Journal Watch‘s editor-in-chief, and Dr. Seemant Chaturvedi, a University of Maryland neurologist who serves on CREST-2’s executive committee.
[Running time: 16 minutes]
NEJM Journal Watch coverage of a recent JAMA paper on the topic.
The post Podcast 295: How should clinic...
2022-07-0615 minClinical ConversationsPodcast 284: The clinical situation in UkraineSome 85 years ago Guernica was bombed, and after that came Dresden, Coventry, Hiroshima, Bach Mai, and the rest. This episode of Clinical Conversations asks how it might be possible to help clinicians under bombardment in Ukraine. As you will hear, one hospital in Chernihiv keeps all but essential staff away from its buildings when they are not on duty — for fear of losing them to Russian attacks.
A neurologist in Chernihiv, Serhiy Kareta, and a Ukrainian American trauma surgeon based in Philadelphia, Roxolana Horbowyj, join the Mass. General’s Ali Raja and NEJM Group’s Joe Elia in a c...
2022-03-0819 min
NEJM InterviewsNEJM Interview: Dr. Michele Evans on the role that public policies have played in exacerbating health inequities in the United States.Dr. Michele Evans is a senior investigator and the deputy scientific director at the National Institute on Aging and a member of the Journal's Editorial Board. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. M.K. Evans. Health Equity — Are We Finally on the Edge of a New Frontier? N Engl J Med 2020;383:997-999.
2020-09-0914 min
Curbside ConsultsNEJM Resident 360 QI Challenge Winning Submission with Dr. Elissa FalconerIn this special episode of Curbside Consults, we interview Dr. Elissa Falconer, the team leader of the NEJM Resident 360 QI Challenge winning submission. Dr. Falconer is a general surgery resident at Atlanta VA Healthcare System. The title of their quality improvement...
2020-09-0915 minNEJM InterviewsNEJM Interview: Dr. Richard Schilsky on milestones in the prevention and treatment of cancer in the United States.Dr. Richard Schilsky is the chief medical officer and executive vice president of the American Society of Clinical Oncology and a member of the Journal’s Editorial Board. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. R.L. Schilsky and Others. Progress in Cancer Research, Prevention, and Care. N Engl J Med 2020;383:897-900.
2020-09-0216 minClinical ConversationsPodcast 273: The journals and the pandemic — NEJMEric Rubin is editor-in-chief of the New England Journal of Medicine.
I asked him how COVID-19 has affected that journal, which has been around since the War of 1812 and seen its share of pandemics.
Listen in — it’s the first in a planned series of interviews with the editors of the principal clinical journals.
Running time: 19 minutes
NEJM’s Covid-19 resources page
TRANSCRIPT
Joe Elia: Welcome to Clinical Conversations. I’m your host, Joe Elia.
Dr. Eric Rubin, a specialist in infectious diseases, took over the rein...
2020-08-2918 minNEJM InterviewsNEJM Interview: Dr. Elizabeth McGlynn on why efforts to improve health care quality have often been unsuccessful and where we can go from hereDr. Elizabeth McGlynn is vice president at Kaiser Permanente Research and executive director of the Kaiser Permanente Center for Effectiveness and Safety Research. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E.A. McGlynn. Improving the Quality of U.S. Health Care — What Will It Take? N Engl J Med 2020;383:801-803.
2020-08-2612 minNEJM InterviewsNEJM Interview: Dr. Justin Berk on starting patients recently released from incarceration on treatment for opioid use disorder.Dr. Justin Berk is an assistant professor in the Departments of Medicine and Pediatrics at Warren Alpert Medical School of Brown University. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J. Berk. A Good Place to Start — Low-Threshold Buprenorphine Initiation. N Engl J Med 2020;383:701-703. H.L.F. Cooper and Others. When Prescribing Isn’t Enough — Pharmacy-Level Barriers to Buprenorphine Access. N Engl J Med 2020;383:703-705.
2020-08-1910 minNEJM InterviewsNEJM Interview: Dr. Katherine Baicker on assessments of health care spending in the United States and moving toward higher-value use of resources.Dr. Katherine Baicker is dean of the University of Chicago Harris School of Public Policy. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. K. Baicker and A. Chandra. Do We Spend Too Much on Health Care? N Engl J Med 2020;383:605-608.
2020-08-1210 minClinical ConversationsPodcast 272: And now for something completely different… almostDr. Paul Sax writes the closest thing that the NEJM Group has to humor. He’s serious, of course, since his blog “HIV and ID Observations” concerns all things infectious . But he sprinkles in the odd cartoon or links to … dog videos, fer cryin’ out loud.
He scours the ID literature (and we must include the social-media literature in that category) for interesting stuff to write about, seems to have a knack for summarizing whole conferences in 750 words, and often manages to give his readers a reason to smile in these fretful times.
We decided to catch u...
2020-08-0809 minNEJM InterviewsNEJM Interview: Dr. Donald Berwick on the history and challenges of measuring and improving health care quality in the United States.Dr. Donald Berwick is president emeritus and a senior fellow at the Institute for Healthcare Improvement. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. D.M. Berwick and C.K. Cassel. The NAM and the Quality of Health Care — Inflecting a Field. N Engl J Med 2020;383:505-508.
2020-08-0510 minNEJM InterviewsNEJM Interview: Dr. Caroline Buckee on the uses — and limitations — of epidemiologic modeling to predict the spread of Covid-19.Dr. Caroline Buckee is the associate director of the Center for Communicable Disease Dynamics at the Harvard T.H. Chan School of Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. I. Holmdahl and C. Buckee. Wrong but Useful — What Covid-19 Epidemiologic Models Can and Cannot Tell Us. N Engl J Med 2020;383:303-305. E.C. Schneider. Failing the Test — The Tragic Data Gap Undermining the U.S. Pandemic Response. N Engl J Med 2020;383:299-302.
2020-07-2210 minNEJM InterviewsNEJM Interview: Dr. Michelle Morse on how academic medical centers can engage with social movements to confront inequities in health care practices.Dr. Michelle Morse is an assistant professor at Harvard Medical School and cofounder of EqualHealth. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. M. Morse and J. Loscalzo. Creating Real Change at Academic Medical Centers — How Social Movements Can Be Timely Catalysts. N Engl J Med 2020;383:199-201.
2020-07-1516 minNEJM InterviewsNEJM Interview: Dr. Martin Roland on opportunities for using socially oriented interventions when illnesses are influenced by social circumstances.Dr. Martin Roland is an emeritus professor of health services research at the University of Cambridge and a fellow at Murray Edwards College. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. M. Roland, S. Everington, and M. Marshall. Social Prescribing — Transforming the Relationship between Physicians and Their Patients. N Engl J Med 2020;383:97-99.
2020-07-0810 minNEJM InterviewsNEJM Interview: Dr. Anthony Fauci on progress made during the past four decades of the HIV/AIDS pandemic and ongoing efforts to end this threat.Dr. Anthony Fauci is the director of the National Institute of Allergy and Infectious Diseases. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. A.S. Fauci and H.C. Lane. Four Decades of HIV/AIDS — Much Accomplished, Much to Do. N Engl J Med 2020;383:1-4.
2020-07-0118 minCurbside ConsultsStatistical Review − Secondary Outcomes with Dr. David HarringtonIn this episode of Curbside Consults: Statistical Review, we explore the interpretation of secondary outcomes in clinical trials using the following two articles recently published in NEJM: Bonaca MP et al. Rivaroxaban in Peripheral Artery Disease after Revascularization...
2020-06-2521 minNEJM InterviewsNEJM Interview: Dr. Pamela Hartzband on lessons from organizational psychology for ameliorating physician burnout.Dr. Pamela Hartzband is an endocrinologist at Beth Israel Deaconess Medical Center and an assistant professor at Harvard Medical School. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. P. Hartzband and J. Groopman. Physician Burnout, Interrupted. N Engl J Med 2020;382:2485-2487.
2020-06-2411 minNEJM InterviewsNEJM Interview: Dr. Eric Rubin and Dr. Lindsey Baden on the challenges of safe reopeningEric Rubin is the Editor-in-Chief of the Journal. Lindsey Baden is a Deputy Editor of the Journal. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E.J. Rubin, L.R. Baden, and S. Morrissey. Audio Interview: The Challenges of Safe Reopening. N Engl J Med 2020;382:e113.
2020-06-2417 minNEJM InterviewsNEJM Interview: Dr. Debra Weinstein on the announcement that scores for Step 1 of the U.S. Medical Licensing Examination will be reported as pass or fail.Dr. Debra Weinstein is vice president for graduate medical education at Mass General Brigham and a member of the Journal’s Perspective Advisory Board. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. C.G. Prober. Grading Changes for USMLE Step 1 — A Golden Opportunity to Recalibrate Medical Education Priorities. N Engl J Med 2020;382:2385-2387. L.L. Willett. The Impact of a Pass/Fail Step 1 — A Residency Program Director’s View. N Engl J Med 2020;382:2387-2389.
2020-06-1711 minNEJM InterviewsNEJM Interview: Dr. Eric Rubin and Dr. Lindsey Baden on a look at SARS-CoV-2 transmissionEric Rubin is the Editor-in-Chief of the Journal. Lindsey Baden is a Deputy Editor of the Journal. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E.J. Rubin, L.R. Baden, and S. Morrissey. Audio Interview: A Look at SARS-CoV-2 Transmission. N Engl J Med 2020;382:e112.
2020-06-1720 minNEJM InterviewsNEJM Interview: Dr. Benjamin Sommers on increased pressure on state Medicaid programs caused by Covid-19 and policies for strengthening Medicaid.Dr. Benjamin Sommers is a primary care internist and a professor of health policy and economics at the Harvard T.H. Chan School of Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J. Gruber and B.D. Sommers. Paying for Medicaid — State Budgets and the Case for Expansion in the Time of Coronavirus. N Engl J Med 2020;382:2280-2282.
2020-06-1010 minNEJM InterviewsNEJM Interview: Dr. Eric Rubin, Dr. Lindsey Baden, and Dr. Michele Evans on the impact of Covid-19 on minority communitiesEric Rubin is the Editor-in-Chief of the Journal. Lindsey Baden is a Deputy Editor of the Journal. Michele Evans is a Senior Investigator and Deputy Scientific Director at the National Institute on Aging and a member of the Journal’s editorial board. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E.J. Rubin and Others. Audio Interview: The Impact of Covid-19 on Minority Communities. N Engl J Med 2020;382:e111.
2020-06-1019 minNEJM InterviewsNEJM Interview: Dr. Erin Fraher on opportunities for expanding health workforce capacity during the Covid-19 pandemic.Dr. Erin Fraher is the director of the Carolina Health Workforce Research Center at the University of North Carolina at Chapel Hill. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E.P. Fraher and Others. Ensuring and Sustaining a Pandemic Workforce. N Engl J Med 2020;382:2181-2183.
2020-06-0313 minNEJM InterviewsNEJM Interview: Dr. Eric Rubin and Dr. Lindsey Baden on diagnosis and early treatment of Covid-19Eric Rubin is the Editor-in-Chief of the Journal. Lindsey Baden is a Deputy Editor of the Journal. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E.J. Rubin, L.R. Baden, and S. Morrissey. Audio Interview: Diagnosis and Early Treatment of Covid-19. N Engl J Med 2020;382:e103.
2020-06-0321 minNEJM InterviewsNEJM Interview: Dr. Lisa Rosenbaum on how health care workers have responded to the challenges of caring for patients during the Covid-19 pandemic.Dr. Lisa Rosenbaum is a national correspondent for the Journal. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. L. Rosenbaum. Harnessing Our Humanity — How Washington’s Health Care Workers Have Risen to the Pandemic Challenge. N Engl J Med 2020;382:2069-2071.
2020-05-2715 minNEJM InterviewsNEJM Interview: Dr. Eric Rubin and Dr. Lindsey Baden on new data on remdesivir in Covid-19Eric Rubin is the Editor-in-Chief of the Journal. Lindsey Baden is a Deputy Editor of the Journal. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E.J. Rubin, L.R. Baden, and S. Morrissey. Audio Interview: New Data on Remdesivir in Covid-19. N Engl J Med 2020;382:e94.
2020-05-2721 minNEJM InterviewsNEJM Interview: Dr. Eric Rubin and Dr. Lindsey Baden on capitalizing on immune responses to Covid-19Eric Rubin is the Editor-in-Chief of the Journal. Lindsey Baden is a Deputy Editor of the Journal. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E.J. Rubin, L.R. Baden, and S. Morrissey. Audio Interview: Capitalizing on Immune Responses to Covid-19. N Engl J Med 2020;382:e93.
2020-05-2020 minNEJM InterviewsNEJM Interview: Dr. Nicole Lurie on rapid vaccine development, including new tools to facilitate vaccine testing and manufacturing and persistent challenges.Dr. Nicole Lurie is a strategic advisor to the CEO of the Coalition for Epidemic Preparedness Innovations. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. N. Lurie and Others. Developing Covid-19 Vaccines at Pandemic Speed. N Engl J Med 2020;382:1969-1973.
2020-05-2013 minClinical ConversationsPodcast 257: Here comes the summer after COVID-19Four weeks ago — in early March — I interviewed Dr. Renee Salas about climate change and clinical medicine.
Back in those halcyon days, COVID-19 was very much a gathering storm, but it had not yet slammed into the United States.
Here we are, over 10,000 U.S. deaths later in early April, not having heard of much else but the disease.
I thought to use this interview now, both to give listeners a small break from “The Virus” — as President Donald Trump refers to it — and to remind us how quickly things can change on the planet.
2020-04-0617 minCurbside ConsultsStatistical Review - Studying Outbreaks with COVID-19In this statistical review episode of Curbside Consults, we explore descriptive epidemiology studies of the COVID-19 outbreak using an article by Guan and colleagues published online in NEJM on February 28, 2020. To help explain the approach to outbreak study analysis...
2020-04-0119 minClinical ConversationsPodcast 260: Interview with a Broward County, Florida, emergency room physicianThis time we talk with Dr. Julian Flores, who works in a Broward County, Florida, emergency room.
When he was interviewed, the count of Covid-19 cases stood at 412, less than 12 hours later, the new number was 505, as of this posting — on Friday near noon Eastern — it’s at 614. Flores is expecting the wave to hit hard there. Broward is home to Fort Lauderdale (think spring break) and Pompano Beach (think aging retirees). Couple those demographics with a lack of easy testing for the virus, and you’ve got a worrisome situation.
Links of interest:
NEJM P...
2020-03-2713 minCurbside ConsultsNEJM Resident 360 QI Challenge with the NEJM Editorial Fellows 2019-20In this special episode of Curbside Consults, this year’s NEJM Editorial Fellows discuss Quality Improvement (QI) in residency and the launch of the NEJM Resident 360 QI Challenge.
2020-02-2109 minClinical ConversationsPodcast 244: Colchicine after myocardial infarctionThe anti-inflammatory colchicine is powerful and cheap. It’s thought that, because cardiovascular problems often stem from inflammation, colchicine could help prevent secondary events after MI. That’s what Jean-Claude Tardif and an international group of colleagues set out to investigate.
The group reports in the NEJM that daily low-dose colchicine was associated with a lower rate of a composite endpoint than a placebo: death from cadiovascular causes, resuscitated cardiac arrest, MI, stroke, or urgent hospitalization leading to coronary revascularization.
New England Journal of Medicine report
Editorial commentary in NEJM
Harlan Krum...
2019-11-2820 minCurbside ConsultsNEJM Editorial Fellowship 2018/2019 Wrap-UpTogether with Dr. David Harrington, 2018/2019 NEJM Editorial Fellows Angie, Angela, and Amanda summarize and wrap up the NEJM experience.
2019-10-1617 minCurbside ConsultsStatistical Review – Missing Data with Dr. David HarringtonMissing data are common in randomized, controlled trials. Why does this happen? How do we interpret these missing data? In this episode of Curbside Consults, Dr. David Harrington, statistical editor at the NEJM, joins us for a discussion on missing data and how to interpret missing data in studies.
2019-09-2017 minCurbside ConsultsOsteoporosis with Dr. Clifford J. RosenOsteoporosis affects more than 10 million people living in the United States. Although a number of medications are available for treatment of osteoporosis, it remains undertreated. In this episode of Curbside Consults, Dr. Clifford J. Rosen, Professor of Medicine at Tufts University School of Medicine and Associate Editor at the NEJM, joins us to...
2019-09-0434 minCurbside ConsultsStatistical Review – Early Trial Cessation – When, Why and How to Interpret with Dr. David HarringtonClinical trials can be stopped early for a range of reasons. But when that happens, it can be tricky to interpret the results and to understand the reasons why the trial was stopped in the first place. Join us in this episode of Curbside Consults with Dr. David Harrington, statistical editor at the NEJM, as we discuss...
2019-07-2410 minCurbside ConsultsTime Limits for Thrombolysis in Acute Ischemic Stroke with Dr. Steven FeskeIntravenous thrombolysis has been an essential component in the management of acute ischemic stroke. Current guidelines recommend that thrombolysis be administered within 3 hours of the onset of first neurologic symptoms. However, two recent trials published in NEJM challenge this time paradigm. In this episode of Curbside Consults...
2019-07-1128 minCurbside ConsultsStatistical Review – Pragmatic Trials with Dr. David HarringtonPractical or pragmatic trials are designed to show the effectiveness of an intervention in the complex clinical setting of daily practice. But what makes a trial pragmatic? Can a clinical trial ever be completely pragmatic? Join us in this episode of Curbside Consults with Dr. David Harrington, statistical editor at the NEJM, as we discuss the elements...
2019-06-2611 minCurbside ConsultsStatistical Review – Composite Outcomes with Dr. David HarringtonComposite outcomes are frequently used as primary outcomes in randomized-controlled trials and observational studies. Why are they used? What are the limitations of their use? How are composite outcomes interpreted? Join us in this episode as Dr. David Harrington, statistical editor at the NEJM, helps breakdown composite outcomes.
2019-05-3010 minCurbside ConsultsStatistical Review – Non-Inferiority Trials with Dr. David HarringtonEver read a paper and feel a bit confused about all the statistical jargon and how to properly interpret the findings? At NEJM Resident 360, we’re bringing you Statistical Review which aims to cover some key areas in research methodology and trial design. On this episode, Dr David Harrington, our statistical editor here at the NEJM...
2019-05-0114 minCurbside ConsultsStatistical Review – Power with Dr. David HarringtonEver read a paper and feel a bit confused about all the statistical jargon and how to properly interpret the findings? At NEJM Resident 360, we’re trying something new and bringing you Statistical Review which aims to cover some key areas in research methodology and trial design. On this episode, Dr. David Harrington our statistical editor here...
2019-03-2915 minCurbside ConsultsStatistical Review – Intention-to-Treat Versus Per-Protocol AnalysesEver read a paper and feel a bit confused about all the statistical jargon and how to properly interpret the findings? At NEJM Resident 360, we’re trying something new and bringing you Statistical Review which aims to cover some key areas in research methodology and trial design. On this episode, we discuss intention-to-treat and per-protocol...
2019-02-0412 minCurbside ConsultsWorsening Asthma Symptoms and Preventing Asthma Exacerbations with Dr. Jeff DrazenWinter is upon us and asthma exacerbations are on the rise. But how well can clinicians and patients predict and prevent these asthma exacerbations before they start? NEJM Editor-in-Chief and Pulmonologist Dr. Jeff Drazen discusses the challenge clinicians and patients face in the setting of worsening asthma symptoms, also known as...
2019-01-0425 minCurbside ConsultsStatistical Review – P-values, Outcomes, Point-estimates and Confidence IntervalsEver read a paper and feel a bit confused about all the statistical jargon and how to properly interpret the findings? At NEJM Resident 360, we’re trying something new and bringing you Statistical Review which aims to cover some key areas in research methodology and trial design. On this episode, we aim to cover basic ground over study...
2018-12-0512 minCurbside ConsultsAcute MI and Cardiogenic Shock with Dr. John JarchoEvery medical resident will need to manage acute myocardial infarction at some stage. But what makes a patient with acute MI and cardiogenic shock more of a challenge to manage? NEJM Deputy Editor and Cardiologist Dr John Jarcho discusses the details around the pathophysiology and management in these patients and the recent paper...
2018-11-1328 minClinical ConversationsPodcast 217: Aspirin and rivaroxaban “comparably effective and safe” for prophylaxis after arthroplastyThe EPCAT II trial examined whether aspirin and rivaroxaban were clinically equivalent in the extended prophylaxis of venous thromboembolism after hip or knee replacement. They proved “comparably effective and safe,” according to our guest, Dr. David Anderson, the study’s first author. An editorial in the New England Journal of Medicine, where the study appeared in February, calls the results practice-changing. One thing was sure from the outset — aspirin is cheaper than rivaroxaban by orders of magnitude.
A note to listeners: Dr. Anderson and I conducted the interview over several sessions, so the first-half audio sounds a bit roug...
2018-03-0911 minCurbside ConsultsIV Fluids and Glucocorticoids for Sepsis with Dr. Kathryn HibbertIn this interview, Dr. Kathryn Hibbert reviews the biology underlying the effects of various fluids on the body and how sepsis disrupts the body’s natural response to corticosteroids. We also discuss the major points from these four new papers in the March 1, 2018 issue of NEJM and prior literature to get you up to speed on the evidence behind practice.
2018-03-0147 minClinical ConversationsPodcast 195: Pioglitazone for secondary prevention?
Pioglitazone, long known to increase insulin sensitivity, has been “mostly relegated to use in unusual conditions such as lipodystrophies” after its drug class, the thiazolidinediones, “fell from grace” in the words of our guest.
Dr. Clay Semenkovich has just written an editorial comment on a study in the New England Journal of Medicine. That study showed a benefit from pioglitazone use in the secondary prevention of vascular events among patients with insulin resistance (but not diabetes) who’d had a recent ischemic stroke or TIA.
He discusses the implications of those findings and, given the...
2016-02-1810 minClinical ConversationsPodcast 183: An Obesity ‘Switch’ in the Genome DescribedThere’s a kind of “wall switch” in the human genome that’s been newly described. It seems to be able to turn on and off genes controlling the efficiency with which we burn fat.
The study describing the finding in the New England Journal of Medicine reads like a genetic research tour-de-force, showing how the whole circuit is controlled by a single variation in a nucleotide sequence.
The study’s senior author, MIT’s Manolis Kellis, examines the switch and its implications.
[running time: 26 minutes]
NEJM study (free)
NEJM editorial...
2015-08-2125 minClinical ConversationsPodcast 180: A sketch of community-acquired pneumoniaHow Webster defined it 90 years ago.
The CDC’s Seema Jain is our guest, talking about a study she did with her team to characterize the causes of community-acquired pneumonia in U.S. adults. (They don’t mention finding Webster’s Micrococcus lanceolatus.) Medicine has come a long way since 1925, but Dr. Jain says that clinicians still need better diagnostic tools to pinpoint the causes of CAP in individual patients.
Using five hospitals in Chicago and Nashville, Jain’s team surveyed over 2000 adult patients admitted with radiographic evidence of CAP during a 30-month period. Also included i...
2015-07-1918 minClinical ConversationsPodcast 173: Sensible Sodium Levels in View at LastRunning time: 9 minutes
In the light of the New England Journal of Medicine‘s recent publication three papers on sodium intake and its implications for cardiovascular disease, blood pressure, and excess mortality, we thought we’d speak again with Dr. Jan Staessen, who surprised a lot of people 3 years ago with a paper in JAMA warning against population-wide sodium reductions. His research showed that cutting sodium intakes to levels recommended by the U.S. Dept. of Agriculture was associated in his cohort with an increase in cardiovascular risk.
Dr. Staessen kindly agreed to serve as our...
2014-08-3008 minClinical ConversationsPodcast 155: What’s wrong with U.S. healthcare and what will save it?Dr. Arnold Relman, longtime observer of the U.S. healthcare system and editor emeritus of the New England Journal of Medicine, proposes two major reforms: First, private insurance companies should leave the healthcare field, and second, physicians should organize into multispecialty practices.
His proposals, just published in BMJ, grow out of his alarmed observation — some 30 years ago in the NEJM — of the rise of the “new medical-industrial complex.”
Links:
BMJ essay (free abstract)
NEJM 1980 article (free abstract)
The post Podcast 155: What’s wrong with U.S. healthcare and what will...
2012-05-1412 minClinical ConversationsPodcast 80: Bisphosphonates and atypical hip fractures — how large is the risk?We talk with three of the academic authors of a New England Journal of Medicine study that pooled data from a few studies in an attempt to examine the possible link between use of bisphosphonates and femoral-shaft fractures.
Interview-related links:
Physician’s First Watch coverage
NEJM paper
NEJM editorial
FDA statement
News-related links:
Aspirin ineffective in preventing miscarriage
BNP-guided therapy for heart failure
Have kids at risk carry two epi-pens
Rotarix contamination
The post Podcast 80: Bisphosphonates and atypical hip fractures — how large is the risk? first appeared on Clinical Conversations.
2010-03-2713 minClinical ConversationsPodcast 27: Dr. Steven E. Sobol talks with us about his paper on trends in pediatric head-and-neck infections from S. aureus — an increasing percentag...The 6-year period 2001 – 2006 saw an increase from 12 to 28 in the percentage of S. aureus infections among head-and-neck infections in childen that were methicillin resistant. This 16-point jump is concerning, and we talk with an author of the paper documenting that increase.
Also, we’d like to know: should we be calling this thing here “Admitting Diagnosis” — or something else?
If you would like to comment or offer an idea for a future podcast, please call 617-440-4374.
Links for this podcast:
Steroids and wheezing children
Journal Watch Pediatrics & Adolescent Medicine summary
NEJM prednisolone abstract
NEJM fluticasone abstract
Journal Watch General Medicine c...
2009-01-2612 minClinical ConversationsPodcast 26: Dr. Wayne A. Ray talks about the dangers of sudden cardiac death from antipsychotic drugsNEJM published a paper this week detailing the risks of sudden cardiac death in those taking both typical and atypical antipsychotic drugs. We talk with the paper’s first author Dr. Wayne A. Ray of Vanderbilt University School of Medicine.
If you would like to comment or offer an idea for a future podcast, please call 617-440-4374.
Links for this podcast:
Simple Checklist Reduces Postoperative Complications
NEJM article on checklists
Surgical safety checklist
Influenza A Treatment Recommendations Emphasized
CDC recommendations
Vicks VapoRub May Cause Respiratory Distress in Infants, Animal Study Suggests
Chest article
Measuring Fractional Flow Reserve During PCI Im...
2009-01-1814 minClinical ConversationsPodcast 13: News and interview with Dr. Stephen Hetz, co-editor of “War Surgery in Afghanistan and Iraq” and director of medical education at Beaumont...This week’s podcast includes an interview with Stephen Hetz, co-editor of the recently published book “War Surgery in Afghanistan and Iraq.”
Journal Watch links
Thrombolysis for Stroke Within 4.5 Hours Is Safe and Effective
Extending the Time Frame for Alteplase: The ECASS III Trial
Continuous Glucose Monitoring in Diabetic Pregnant Women
Maternal Influenza Vaccination Reduces Infant Influenza, Febrile Respiratory Illness
Maternal Influenza Immunization Protects Infants
Novel Approach to Infant Influenza
Survival After MI Better with Drug-Eluting Than with Bare-Metal Stents
Story links
NEJM alteplase abstract
NEJM alteplase editorial
BMJ glucose monitoring article
NEJM on maternal influenza vaccin...
2008-09-2823 minClinical ConversationsPodcast 12: News and interview with Dr. Anne Schuchat, Director of CDC’s National Center for Immunization and Respiratory DiseasesThis week’s podcast includes an interview with Anne Schuchat about U.S. childhood immunization rates, along with the usual news roundup.
Journal Watch links
Physical Activity May Boost Cognitive Function in Older Adults
Vytorin (Simvastatin + Ezetimibe) Shows Little Benefit for Aortic Stenosis
New Questions and a Few Answers on Vytorin and Cancer Risks
Vytorin: Navigating Uncharted Waters
Omega-3s Improve Outcomes in Heart Failure Patients, Rosuvastatin Does Not
Exercise and cognitive impairment
http://firstwatch.jwatch.org/cgi/content/full/2008/903/3
http://jama.ama-assn.org/cgi/content/full/300/9/1027
http://jama.ama-assn.org/cgi/content/extract/300/9/1077
...
2008-09-0615 minClinical ConversationsPodcast 10: News and interview with Dr. Michel Ovize, Professor of Physiology and Cardiology, Universite Claude Bernard, LyonThis week, after our usual news roundup, Michel Ovize is our guest, and he talks about preventing reperfusion injury during interventions for myocardial infarction. It all has to do with mitochondrial pores.
Journal Watch links
New NAMS Position Statement on Postmenopausal Hormone Therapy
Cyclosporine Attenuates Reperfusion Injury During Stenting
Does Cyclosporine Protect Against Myocardial Reperfusion Injury?
Pregestational diabetes
http://www.ajog.org/article/S0002-9378(08)00639-X/abstract
Chronic lymphocytic leukemia
http://www.ncbi.nlm.nih.gov/pubmed/18216293?dopt=Abstract
Encephalitis
http://infectious-diseases.jwatch.org/cgi/content/full/2008/730/3
http://www...
2008-08-0214 min